Bio Essence Corporation
BIOE · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $1 | $1 | $1 |
| % Growth | -41.3% | -11.3% | -30% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $1 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 67% | 50.3% | 52.8% | 33.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $1 | $1 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | -$0 | -$1 | -$1 | -$1 |
| % Margin | -141.8% | -143.1% | -82.2% | -96.6% |
| Other Income/Exp. Net | -$1 | -$0 | -$0 | $0 |
| Pre-Tax Income | -$2 | -$1 | -$1 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | -404% | -176.2% | -130.3% | -72.9% |
| EPS | -0.034 | -0.022 | -0.025 | -0.02 |
| % Growth | -54.3% | 9% | -25% | – |
| EPS Diluted | -0.034 | -0.022 | -0.025 | -0.02 |
| Weighted Avg Shares Out | 38 | 36 | 33 | 33 |
| Weighted Avg Shares Out Dil | 38 | 36 | 33 | 33 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$1 | -$0 | -$1 |
| % Margin | -482.1% | -138.7% | -79.9% | -63.1% |